New and promising strategies in the management of bladder cancer

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2015, Pages 105-112

  Apolo, Andrea B ^a   Vogelzang, Nicholas J ^a   Theodorescu, Dan ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

ADJUVANT CHEMOTHERAPY; ANTAGONISTS AND INHIBITORS; GENETICS; HUMAN; MUTATION; NEOADJUVANT THERAPY; PATHOLOGY; URINARY BLADDER NEOPLASMS;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; HUMANS; MUTATION; NEOADJUVANT THERAPY; PROGRAMMED CELL DEATH 1 RECEPTOR; URINARY BLADDER NEOPLASMS;

EID: 84988904355     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.14694/EdBook_AM.2015.35.105     Document Type: Review

References (0)